NIVF
NASDAQ
TH
NewGenIvf Group Limited - Class A Ordinary Shares
$2.13
▼ $-0.03
(-1.39%)
Vol 19K
8
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$909K
P/E
0.1
ROE
92.6%
Margin
12.4%
D/E
16.90
Beta
-0.12
52W
$1–$2450
Price Chart
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 7.8% | — | — | — | 7.8% | 92.6% |
| P/E (TTM) | 7.62 | — | — | — | 1.49 | 0.05 |
| Net Margin | 35.6% | — | — | — | 12.5% | 12.4% |
| Gross Margin | 15.5% | — | — | — | 31.5% | 31.5% |
| D/E Ratio | 36.96 | 10.42 | 10.42 | 10.42 | 37.02 | 16.90 |
| Current Ratio | 2.21 | 1.17 | 1.17 | 1.17 | 2.21 | 3.43 |
Key Ratios
ROA (TTM)
96.8%
P/S (TTM)
0.19
EPS (TTM)
$104.69
52W High
$2450.00
52W Low
$0.78
$0.78
52-Week Range
$2450.00
How does NIVF compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
NIVF valuation vs Health Care peers
P/E ratio
0.1
▼
100%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
0.2
▼
93%
below
peers
(2.6)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼
0%
below
peers
(2.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
NIVF profitability vs Health Care peers
ROE
92.6%
▲
340%
above
peers
(-38.5%)
vs Peers
vs Industry
Top tier
Net margin
12.4%
▲
150%
above
peers
(-24.7%)
vs Peers
vs Industry
Top tier
Gross margin
31.5%
▼
40%
below
peers
(52.9%)
vs Peers
vs Industry
Weak
ROA
96.8%
▲
556%
above
peers
(-21.2%)
vs Peers
vs Industry
Top tier
NIVF financial health vs Health Care peers
D/E ratio
16.9
▼
12%
below
peers
(19.3)
vs Peers
vs Industry
In line
Current ratio
3.4
▲
59%
above
peers
(2.2)
vs Peers
vs Industry
Below avg
Beta
-0.1
▼
111%
below
peers
(1.1)
vs Peers
vs Industry
More volatile
NIVF fundamentals radar
NIVF
Peer median
Industry
NIVF profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NIVF vs peers: key metrics
Latest News
No related news yet